Genmab A/S Annual Shareholders Meeting Transcript
/-
Good afternoon, and welcome to Genmab's 2022 Annual General Meeting. We are pleased to once again see so many of you in person, finally. And welcome also those of you joining us via webcast.
I'm Deirdre Connelly, Chair of Genmab's Board of Directors. I would like to begin by introducing the other members of our Board: Deputy Chair, Pernille Erenbjerg; Anders Gersel Pedersen; Paolo Paoletti, who's connecting through webcast; and Rolf Hoffmann. We also have 3 newly elected employee Board members: Martin Schultz, Takahiro Hamatani, and Mijke Zachariasse. I would like to thank our previous employee Board members: Peter Storm Kristensen and Rima Nassar for their contributions over the years.
Next, our company's executive managers. Jan van de Winkel, Genmab's Chief Executive Officer; Anthony Pagano, the company's Chief Financial Officer; Judith Klimovsky, Chief Developmental Officer; Anthony Mancini, Genmab's Chief Operating Officer; Birgitte Stephensen, Genmab's Chief Legal Officer; and Chris
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |